Skip to search.
 All Ordinaries Up 0.04%

More On NRT.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Novogen Ltd (NRT.AX)

-ASX
0.14 Up 0.01(3.57%) 15:52
Add to Portfolio
Prev Close:0.14
Open:0.14
Bid:0.14
Ask:0.15
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.14 - 0.14
52wk Range:0.08 - 0.45
Volume:946,791
Avg Vol (3m):1,814,620
Market Cap:61.48M
P/E (ttm):N/A
EPS (ttm):-0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :-2.07
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novogen Limited engages in the pharmaceutical research and development business in Australia. The company primarily has two drug technology platforms, which include superbenzopyran (SBPs) and anti-tropomyosin (ATMs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback